8 min read

EverHint Signal — EMA10 × EMA30 Crossover — November 19, 2025

A fresh batch of EMA10 × EMA30 crossovers highlights strong upside momentum in SEMR, CASY, ONON, and steady trends in PEP and PBA, while oversold names like REYN and ACM dominate the sell side. An experimental, data-driven look at early trend shifts across sectors.

November 19, 2025


What This Signal Is (Quick)

Today’s report looks at an EMA10 × EMA30 crossover – a fast momentum setup that compares the short 10-day exponential moving average (EMA10) to the slower 30-day exponential moving average (EMA30):

  • EMA10 > EMA30 → Buy bias: short-term momentum has overtaken the 1-month trend, often an early bullish inflection.
  • EMA10 < EMA30 → Sell bias: short-term momentum has rolled under the 1-month trend, often an early warning of weakness.

Because EMAs react faster than SMAs, this crossover can catch early turns in trend, but is also susceptible to whipsaws in choppy markets. Today’s scan is treated as an experimental signal for research and back-testing, not a standalone trading system.

All names below come from a rules-based screen layered with:

  • Momentum (RSI-14)
  • Liquidity (ADV in dollars / market cap)
  • Context overlays: insider flows (90 days) and days until the next earnings report

How We Ranked Today (Reader Version)

For 2025-11-19:

  • We split the universe into 📈 Buy signals (EMA10 crossed above EMA30) and 📉 Sell signals (EMA10 crossed below EMA30).
  • Within each side, we ranked only the top 10 names by RSI(14):
    • Buys: highest RSI first (strongest upside momentum)
    • Sells: lowest RSI first (most oversold / weakest near-term momentum)
  • We then overlaid:
    • Net insider activity (last 90 days) → open-market P (purchase) minus S (sale) in USD
    • Days → earnings → days from today’s signal date to the next scheduled earnings (where available)
    • Market cap → helps distinguish small speculative names from large, slower-moving franchises

These signals are meant for idea generation, screening, and back-testing. They are not recommendations to buy or sell any security.


📈 Buy-Side Signals (Top 10 by Momentum)

Top 10 EMA10 > EMA30 Buys

Rank Ticker Sector Last ($) RSI(14) Insider Net (90d) Days → Earnings Market Cap
1 SEMR Technology 11.76 81.4 -$54K $1.75B
2 CWST Industrials 91.92 79.4 84 $5.75B
3 CASY Consumer Cyclical 556.71 77.8 19 $20.70B
4 ONON Consumer Cyclical 43.30 74.1 $14.20B
5 AS Consumer Cyclical 34.76 64.0 $19.28B
6 PBA Energy 38.82 59.9 $22.55B
7 RGLD Basic Materials 188.43 59.8 84 $12.36B
8 UPWK Communication Services 18.16 59.4 -$1.2M 84 $2.37B
9 PEP Consumer Defensive 147.11 48.7 76 $201.2B
10 TMDX Healthcare 133.47 47.9 $4.56B

Field notes on today’s buy signals

  • SEMR – Semrush Holdings (Technology)
    Semrush runs a SaaS platform for online visibility management, serving marketers with SEO, paid search and content analytics tools.(Yahoo Finance)
    • RSI is in the low-80s, making this one of the most stretched momentum names on today’s list.
    • Price is well above its 200-day SMA, reflecting a strong existing uptrend.
    • There is modest net insider selling (~$54K) over the last 90 days, which is a small negative overlay.
  • CASY – Casey’s General Stores (Consumer Cyclical)
    Casey’s operates a chain of convenience stores and fuel stations across the U.S. Midwest, with a growing prepared-food business that includes its well-known pizza offering.
    • Elevated RSI near 78 and price trading significantly above the 200-day SMA point to a strong primary uptrend.
    • Earnings are due in ~19 days, which can be both a catalyst and a volatility risk window.
  • ONON – On Holding AG (Consumer Cyclical)
    On is a Swiss performance footwear and sportswear brand, known for its “cloud” running shoes and rapidly growing global presence.
    • RSI is mid-70s, signaling strong momentum.
    • Price is still close to, but currently a bit below its 200-day SMA, suggesting this may be an emerging recovery rather than a fully established long-term uptrend.
  • AS – Amer Sports (Consumer Cyclical)
    Amer Sports owns global sporting brands such as Wilson (racquet sports), Salomon (outdoor gear), Arc’teryx (technical apparel), and Atomic (ski equipment).(MarketScreener)
    • Momentum is positive (RSI mid-60s) with EMA10 crossing above EMA30.
    • Market cap around $19B makes this a sizeable consumer name rather than a micro-cap flier.
  • PBA – Pembina Pipeline (Energy)
    Pembina is a Canadian energy infrastructure company operating pipelines and midstream assets in North America.(Yahoo Finance)
    • RSI near 60 and price slightly above its 200-day SMA reflect a steady constructive trend, rather than an extreme momentum spike.
    • No notable insider buying or selling in the last 90 days in this scan.
  • RGLD – Royal Gold (Basic Materials)
    Royal Gold is a precious metals royalty and streaming company with interests in gold, silver, copper and other metals projects.(Yahoo Finance)
    • RSI just under 60, with price comfortably above the 200-day SMA, fits the profile of an established uptrend.
    • Earnings are ~84 days out, reducing near-term event risk.
  • UPWK – Upwork (Communication Services)
    Upwork operates a global online talent marketplace connecting freelancers with businesses for remote work.(Yahoo Finance)
    • RSI near 59 suggests improving momentum, but there is meaningful net insider selling (~$1.2M) over the last 90 days, which is a cautionary overlay.
    • Next earnings is also around 84 days away.
  • PEP – PepsiCo (Consumer Defensive)
    PepsiCo is a global leader in beverages and snacks, owning brands such as Pepsi, Gatorade, Lay’s, Doritos and more.(Yahoo Finance)
    • RSI is below 50, so this is more of a gentle buy-signal crossover than a momentum chase.
    • Price is slightly above its 200-day SMA, consistent with a long-term uptrend that recently digested prior gains.
    • Earnings in roughly 76 days; recent results showed modest revenue growth supported by higher prices despite soft beverage volumes.(MarketWatch)
  • TMDX – TransMedics Group (Healthcare)
    TransMedics develops organ care systems that keep donor organs viable outside the body for transplantation.(Forbes)
    • RSI just under 50 but price clearly above its 200-day SMA indicates a longer-term uptrend with a fresh momentum inflection.
    • The stock has been volatile around strong revenue growth as adoption of its organ care systems expands.(Investors.com)

Buy-side headline context

Within the dedicated 7-day news window feeding this scan, none of today’s top 10 buy signals show fresh company-specific headlines in the last 2–3 days, which suggests today’s moves are primarily technically driven rather than responding to brand-new news in this short window.


📉 Sell-Side Signals (Top 10 by Weakest Momentum)

Top 10 EMA10 < EMA30 Sells

Rank Ticker Sector Last ($) RSI(14) Insider Net (90d) Days → Earnings Market Cap
1 REYN Consumer Cyclical 23.86 17.8 77 $5.02B
2 ACM Industrials 113.03 17.9 75 $14.97B
3 AGIO Healthcare 22.34 20.2 -$134K 85 $1.30B
4 ES Utilities 65.26 25.6 83 $24.05B
5 MIR Industrials 24.03 25.9 83 $5.33B
6 HRI Industrials 119.74 31.7 85 $3.98B
7 TM Consumer Cyclical 196.78 35.1 77 $256.5B
8 CRI Consumer Cyclical 28.61 36.7 $1.04B
9 QCOM Technology 166.11 37.8 -$2.6M 77 $177.9B
10 EQNR Energy 23.27 39.2 77 $58.99B

Field notes on today’s sell signals

  • Deeply oversold zone (REYN, ACM)
    • REYN – Reynolds Consumer Products makes household goods such as Reynolds wrap, Hefty trash bags and tableware.(StockAnalysis)
    • ACM – AECOM is a large infrastructure consulting and engineering firm.(Wikipedia)
      Both show RSI below 20 with EMA10 under EMA30, a classic oversold profile. Prices are hovering near their 200-day SMAs, which can sometimes act as support in longer-term uptrends.
  • AGIO – Agios Pharmaceuticals (Healthcare)
    Agios is a biopharma company focused on cellular metabolism therapies, particularly in rare hematology.(Yahoo Finance)
    • RSI near 20 and price well below its 200-day SMA highlight a more structurally weak chart.
    • Net insider flows show around $134K in net selling over the last 90 days, adding a small negative overlay.
  • ES – Eversource Energy (Utilities)
    Eversource is a regulated utility holding company providing electric, gas and water services across New England.(Yahoo Finance)
    • RSI mid-20s, EMA10 < EMA30 and price only slightly above its 200-day SMA point to a tired defensive name in a gentle down-drift.
    • Utilities often move with rates and macro risk sentiment more than stock-specific news.
  • MIR – Mirion Technologies (Industrials)
    Mirion provides radiation detection, measurement and monitoring solutions across medical and nuclear end markets.(StockAnalysis)
    • RSI mid-20s with price still above its 200-day SMA suggests a shorter-term pullback within a broader uptrend.
  • TM – Toyota Motor Corporation (Consumer Cyclical)
    Toyota is a global automotive manufacturer across passenger vehicles, trucks and related financial services.(Yahoo Finance)
    • RSI in the mid-30s and EMA10 below EMA30 indicate cooling momentum after an extended run.
    • Price remains above the 200-day SMA, so this still looks more like an intermediate pullback than a broken trend.
  • CRI – Carter’s (Consumer Cyclical)
    Carter’s is a leading marketer of baby and young children’s apparel in North America.(Carter's Investor Relations)
    • RSI mid-30s with price below its 200-day SMA flags a more prolonged down-trend.
    • The company has recently been managing leadership transition amid stock underperformance.(Investopedia)
  • QCOM – Qualcomm (Technology)
    Qualcomm develops and licenses foundational wireless technologies and designs chips for smartphones and connected devices, and is now pushing deeper into AI and data-center silicon.(Wikipedia)
    • RSI high-30s, EMA10 < EMA30 and price still above its 200-day SMA suggest a momentum pause rather than a collapse.
    • There is notable net insider selling (~$2.6M) over the last 90 days in the dataset, which is a non-trivial negative overlay.
    • Recently, Qualcomm announced new AI data-center accelerators and secured its first large customer, aiming to diversify beyond handset chips.(Investors.com)
  • EQNR – Equinor (Energy)
    Equinor is a Norwegian state-backed integrated energy company, historically focused on oil and gas with growing investments in renewables.(Wikipedia)
    • RSI just under 40 with price slightly below the 200-day SMA reflects a mild down-trend, consistent with choppy energy markets.

Sell-side headline context

As on the buy side, our 7-day news window feeding this scan shows no brand-new headlines in the last 2–3 days specifically tagged to these top sell signals, so the weakness here appears more like technical mean-reversion and sector rotation rather than single-stock news shocks.


Field Notes (How to Read This)

1. EMA10 × EMA30 crossover

  • Buy signal: EMA10 crosses above EMA30 → short-term trend accelerates faster than the 1-month trend.
  • Sell signal: EMA10 crosses below EMA30 → short-term trend rolls over vs. the 1-month trend.
  • Crossover systems often enter early in a move but can suffer in sideways, noisy markets.

2. RSI(14)

  • RSI is a bounded momentum oscillator from 0 to 100.
  • Above 70 → overbought / strong upside momentum.
  • 30–70 → neutral trend zone.
  • Below 30 → oversold / strong downside momentum.
  • Today we used RSI to rank the signals, not as a standalone trigger.

3. 200-day SMA

  • A classic proxy for the long-term trend.
  • Price above 200-day SMA → longer-term uptrend bias.
  • Price below 200-day SMA → longer-term downtrend or a deeper correction.
  • Crossovers against the 200-day (e.g., buy signals while still below the 200-day) are often higher-risk counter-trend ideas.

4. Insider Net (90d)

  • We aggregate open-market insider activity over the last 90 days:
    • P (Purchase) → positive cash outlay
    • S (Sale) → negative cash outlay
  • Net Insider (USD) = sum of purchases minus sales (awards, grants, tax moves excluded).
    • Positive → net buying; insiders adding exposure.
    • Negative → net selling; insiders reducing exposure.
  • This is a secondary overlay – it does not override the technical signal, but it helps tilt conviction.

5. Days → Earnings

  • Difference between today’s signal date and the next known earnings date.
  • < 7 days → earnings imminently; high event risk.
  • 7–30 days → approaching catalyst window.
  • > 30 days or none → fewer known near-term scheduled events, barring guidance changes or macro shocks.

Vlad’s Take (EverHint)

Today’s EMA10 × EMA30 scan shows:

  • Buys concentrated in Consumer Cyclical & Energy, with sporting goods / apparel (ONON, AS) and midstream energy (PBA) mixing with gold royalties (RGLD) and digital work platforms (UPWK).
  • Sells tilting toward Industrials and defensives, where some names (ACM, REYN, ES) look washed out but not broken, while others like AGIO, CRI sit below their 200-day SMAs and look more structurally weak.

How one might use this, strictly as an experiment:

  • For momentum longs:
    • Focus on names where EMA10 > EMA30 and price > 200-day SMA (e.g., CASY, RGLD, PEP, TMDX).
    • Consider scaling in with tiered entries rather than all at once, especially when RSI is already >70 (SEMR, CWST, CASY).
  • For pullback or hedge ideas:
    • On the short/hedge side, oversold names like REYN and ACM might rebound sharply if broad markets firm up, so pure shorts there can be tricky.
    • More sustained weakness candidates may be those with RSI low, EMA10 < EMA30, and price below the 200-day SMA (AGIO, CRI, EQNR).
  • Event risk:
    • Several names have earnings in ~2–3 months, giving some breathing room.
    • The few with nearer earnings (such as CASY) carry larger gap risk; sizing and timing matter more there.

Big picture, this remains an experimental scanner, best suited for:

  • Building watchlists
  • Doing post-hoc studies / back-tests on how these crossovers behave across sectors and regimes
  • Combining with your own risk management, timeframes, and fundamental work

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.